Skip to content
Dose Brief
Menu
Head-to-head · Brief Score

CoreAge Rx vs Queen RX

Two GLP-1 providers, one scoreboard. We put CoreAge Rx and Queen RX head-to-head on the published Brief Score — the same six factors, scored the same way.

Higher Brief ScoreNo. 1 · Grade A

CoreAge Rx

Visit CoreAge Rx Full brief →
vs
No. 202 · Grade C

Queen RX

Visit Queen RX Full brief →

The verdict

CoreAge Rx takes this head-to-head.

CoreAge Rx scores 94 to 68 on our six-factor Brief Score — CoreAge publishes different starting offers across its pages; the advertised annual rates require a full year paid upfront.

That doesn't make Queen RX a bad call — it's best for readers comfortable buying a three-month pack who can confirm the dose schedule and refund cutoff before paying. Weigh the six factors below against your own priorities before you decide.

Assume any provider we list may compensate us — we may earn a commission, at no cost to you. It never changes the Brief Score.

Factor by factor

Both providers scored on the six published Brief Score factors. The higher score in each row is marked. See the methodology.

Price Stability
97
46
Supply Reliability
95
67
Transparency
90
88
Access Breadth
93
74
Clinical Oversight
92
78
Track Record
88
63
CoreAge RxBrief Score 94 · 68Queen RX

Price, coverage & the tracker

CoreAge RxQueen RX
Brief Score94/100 (A)68/100 (C)
Semaglutide

From $79/mo

Annual offer: 12 months paid upfront, from $948.

Main site: from $99/mo; confirm the selected offer.

Full price details

From $79/mo on the annual-plan landing offer, based on a 12-month plan paid in full ($948 at that starting rate); main product page separately advertises from $99/mo

$299 three-month starter pack

Displayed sale price; maintenance pack $399. One-time purchase without membership or automatic monthly renewal.

Full price details

Compounded semaglutide offered; calendar-month quote unknown; $299 upfront for three-month starter pack or $399 for maintenance pack

Tirzepatide

From $129/mo

Annual offer: 12 months paid upfront, from $1,548.

Main site: from $149/mo; confirm the selected offer.

Full price details

From $129/mo on the annual-plan landing offer, based on a 12-month plan paid in full ($1,548 at that starting rate); main product page separately advertises from $149/mo

$399 three-month starter pack

Displayed sale price; maintenance pack $499. One-time purchase without membership or automatic monthly renewal.

Full price details

Compounded tirzepatide offered; calendar-month quote unknown; $399 upfront for three-month starter pack or $499 for maintenance pack

CoverageUS only; restrictions by state, confirmed at intakeSays unavailable in CA, KS, LA, MS, NM and WV; confirm medication eligibility elsewhere
Brand-name accessNot confirmedNot confirmed
Oral / sublingualInjection onlyInjection only
On the trackerStableprice stableNewnew to the tracker, no prior reading

CoreAge Rx: The checked annual-plan offer starts at $79/$129 per month on annual prepay; the main product pages still show $99/$149. Confirm the selected offer.

Queen RX: Three-month packs: semaglutide $299 starter/$399 maintenance; tirzepatide $399/$499. One-time upfront purchases, not $100 monthly subscriptions.

Keep comparing

Pricing, states and access reflect each provider's public disclosures at last review; the Brief Score is our editorial judgment per the methodology. Prices change — confirm on each provider's site. Not medical advice; see our disclosure.